Sanofi India Limited is one of the entities of Sanofi in India. It has been in existence since 1956 and it was born under the name of Hoechst Fedco Pharma Private Limited. Sanofi India Limited is listed on Bombay Stock Exchange and National Stock Exchange. The mid-cap stock has a market capitalization of Rs 14,825 crore at the time of writing the story.
It was in news this year when it declared record equity dividend of 1810% and special dividend of 3090%. Check details below:
1. Sanofi India Ltd declared record equity dividend of 4900.00%
The company had declared a record equity dividend of 1810% amounting to Rs 181 per equity share and 3090% special dividend amounting to Rs 309 equity share. According to the board of directors BSE filing, "The Board of Directors of the Company at its Meeting held on 23rd February 2022, recommended payment of final dividend of Rs.181 per equity share of Rs. 10 each and one-time special dividend of Rs. 309 per equity share of Rs. 10 each for the year ended 31st December 2021. The final dividend as well as one-time special dividend will be paid to the members of the Company after declaration of dividend at the Annual General Meeting of the Company scheduled on 26th April 2022."
2. Sanofi India Ltd dividend history
It has a good dividend history and regularly declared dividend in the last 5 years. In the year 2021, it had declared an equity dividend of 1250% amounting to Rs 125 while in the same year it declared a special dividend of 2400% amounting to Rs 240 per share. If the current stock price of Rs 6437 apiece is taken into consideration, the dividend yield is 7.61%. Brokers have upgraded their recommendations or target price for the stock.
3. Sanofi India Ltd Stock Outlook
The current market price of the stock is Rs 6437 apiece. It has touched its 52-week high of Rs 9285 apiece and 52-week low of Rs 6351 apiece. The PE of the stock is 14.30 which is lesser than sector PE of 28.92. The EPS is 450.23. It is a company with strong financial. It has given a return of 54% in 5 years.
4. Sanofi India Ltd Q4 Results
It had declared a net profit of Rs 238 crore in the quarter ending March 2022 with a rise of 63.40% as against Rs 145 crore registered in the previous quarter ending March 2021.
Sanofi India Ltd Overview
Sanofi India Limited is one of the entities through which Sanofi operates in India. It was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited, Hoechst Marion Roussel Limited and Aventis Pharma Limited. Today, it employs more than 3,000 employees across India. Sanofi, one of the world's leading healthcare companies, and its 100% subsidiary - Hoechst GmbH, are the major shareholders of Sanofi India Limited and together hold 60.4% of its paid-up share capital, according to its official website.